Skip to main content

Table 1 Cases, blood sample findings, and PET–CT findings

From: Association between PET–CT accumulation in the hypothalamic/pituitary regions and neuron-specific enolase/primary tumor in limited-stage small cell lung cancer: a case-controlled retrospective study

Factors

Results

Patient background

Cases

19 Cases

Age

70.1 ± 8.8 years

Sex

13 Male, 6 female

Blood samples

White blood cells

7.34 ± 1.56 × 103/µL

Red blood cells

4.26 ± 0.68 × 106/µL

Hemoglobin

13.0 ± 1.8 g/dL

Platelets

288.5 ± 138.6 × 103/µL

Total protein

7.1 ± 0.65 g/dL

Albumin

3.96 ± 0.50 g/dL

NSE

29.5 ± 16.7 ng/mL

CEA

6.36 ± 5.85 ng/mL

PET–CT

SUVmax in the hypothalamic/pituitary region

3.47 ± 0.80

Total volume of hypothalamic/pituitary region

0.52 ± 0.13 mL

TLG of hypothalamic/pituitary region

1.33 ± 0.33 SUV × mL

SUVmax of the primary tumor

13.3 ± 3.5

volume of the primary tumor

42.0 ± 39.7 mL

TLG of the primary tumor

314.9 ± 348.0 SUV × mL

Maximum diameter of primary tumor

40.2 ± 19.0 mm

SUVmax of the lymph node metastases

11.6 ± 4.4

Volume of lymph node metastases

29.6 ± 33.0 mL

TLG of the lymph node metastases

208.6 ± 263.0 SUV × mL

Total tumor volume (primary tumor and lymph node metastases)

70.1 ± 53.0 mL

Total tumor TLG (primary tumor and lymph node metastases

512.6 ± 461.4 SUV × mL

  1. CEA, Carcinoembryonic antigen; NSE, neuron-specific enolase; PET–CT, positron emission tomography–computed tomography; SUVmax, maximum standardized uptake value; TLG, total lesion glycolysis